Dayton Misfeldt Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Dayton Misfeldt.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Dayton Misfeldt. Dayton Misfeldt is a Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and a Interim CEO in SUNESIS PHARMACEUTICALS INC ($SNSS) and a See Remarks in SUNESIS PHARMACEUTICALS INC ($SNSS).

Address: C/O BAY CITY CAPITAL LLC 750 BATTERY STREET, SUITE 400 SAN FRANCISCO 94111 CA

Companies in which Dayton Misfeldt is an Insider

Viracta Therapeutics, Inc.

Trading Symbol: SNSS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dayton Misfeldt: See Remarks, Interim CEO, Director
Holdings: 1,598,260 shares
Current Value: $6,552,866
Latest Transaction: Jul 01 2020
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Dayton Misfeldt

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2020SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonSee RemarksOption ExerciseA0.2660,00015,80460,000
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.41480,000199,152480,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.73480,000348,864480,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.7360,00043,60860,000
Jan 03 2019SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.42200,00083,140200,000
Jul 03 2018SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA2.1225,00053,00025,000
Jul 03 2018SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA2.12200,000424,000200,000

View all Dayton Misfeldt insider transactions.

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

What Happens When a Company Gets Delisted?

When listed on a major exchange, such as the NYSE or Nasdaq, the companies and their stock have to meet several listing requirements on stock price, trading volume, capitalization, disclosure of material information or financial reporting. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter